{"count": 37, "results": [{"_id": "7340890", "pmid": 7340890, "title": "A comparative study of atenolol and metoprolol in the treatment of hypertension.", "journal": "Br J Clin Pharmacol", "authors": ["Rasmussen S", "Arnung K", "Eskildsen PC", "Nielsen PE"], "date": "1981-12-01T00:00:00Z", "doi": "10.1111/j.1365-2125.1981.tb01326.x", "meta_date_publication": "1981 Dec", "meta_volume": "12", "meta_issue": "6", "meta_pages": "887-91", "score": 50074.91, "text_hl": "1 In an open, randomized cross-over investigation of thirteen @SPECIES_9606 @@@patients@@@ (nine and four @SPECIES_9606 @@@women@@@, aged 37-67 years) with mild or moderate @DISEASE_Essential_Hypertension @DISEASE_MESH:D000075222 @@@essential hypertension@@@ a comparison between @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ and @CHEMICAL_Metoprolol @CHEMICAL_MESH:D008790 @@@metoprolol@@@ was carried out in order to study the effects of 50, 100 and 200 mg given once daily on blood @<m>DISEASE_Pressure_Ulcer</m> @DISEASE_MESH:D003668 @@@pressure@@@ and heart rate at rest and during exercise. 2 Before one beta-adrenoceptor blocking drug was replaced by the other in a @SPECIES_9606 @@@patient@@@ an intervening drug-free interval of sufficient length was secured to allow an increase in the blood @<m>DISEASE_Pressure_Ulcer</m> @DISEASE_MESH:D003668 @@@pressure@@@ to pretreatment levels. 3 A maximal fall in blood @<m>DISEASE_Pressure_Ulcer</m> @DISEASE_MESH:D003668 @@@pressure@@@ was achieve with 50 mg @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ once daily, with no further reduction when the dose was increased to 100 mg or 200 mg. ", "citations": {"NLM": "Rasmussen S, Arnung K, Eskildsen PC, Nielsen PE. A comparative study of atenolol and metoprolol in the treatment of hypertension. Br J Clin Pharmacol. 1981 Dec;12(6):887-91. PMID: 7340890", "BibTeX": "@article{7340890, title={A comparative study of atenolol and metoprolol in the treatment of hypertension.}, author={Rasmussen S and Arnung K and Eskildsen PC and Nielsen PE}, journal={Br J Clin Pharmacol}, volume={12}, number={6}, pages={887-91}}"}}, {"_id": "21039760", "pmid": 21039760, "title": "Atenolol blunts blood pressure increase during dynamic resistance exercise in hypertensives.", "journal": "Br J Clin Pharmacol", "authors": ["Gomides RS", "Costa LA", "Souza DR", "Queiroz AC", "Fernandes JR", "Ortega KC", "Junior DM", "Tinucci T", "Forjaz CL"], "date": "2010-11-01T00:00:00Z", "doi": "10.1111/j.1365-2125.2010.03742.x", "meta_date_publication": "2010 Nov", "meta_volume": "70", "meta_issue": "5", "meta_pages": "664-73", "score": 50074.504, "text_hl": "@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ blunts blood @<m>DISEASE_Pressure_Ulcer</m> @DISEASE_MESH:D003668 @@@pressure@@@ increase during dynamic resistance exercise in @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensives@@@.", "citations": {"NLM": "Gomides RS, Costa LA, Souza DR, Queiroz AC, Fernandes JR, Ortega KC, Junior DM, Tinucci T, Forjaz CL. Atenolol blunts blood pressure increase during dynamic resistance exercise in hypertensives. Br J Clin Pharmacol. 2010 Nov;70(5):664-73. PMID: 21039760", "BibTeX": "@article{21039760, title={Atenolol blunts blood pressure increase during dynamic resistance exercise in hypertensives.}, author={Gomides RS and Costa LA and Souza DR and Queiroz AC and Fernandes JR and Ortega KC and Junior DM and Tinucci T and Forjaz CL}, journal={Br J Clin Pharmacol}, volume={70}, number={5}, pages={664-73}}"}}, {"_id": "10425617", "pmid": 10425617, "title": "[Relationship between sympathetic activity and response to treatment with atenolol in hypertensive patients. Investigation group of the study of efficiency and tolerance of atenolol in hypertensive patients with increase in the sympathetic activity].", "journal": "Med Clin (Barc)", "authors": ["de la Sierra A"], "date": "1999-06-19T00:00:00Z", "meta_date_publication": "1999 Jun 19", "meta_volume": "113", "meta_issue": "2", "meta_pages": "41-5", "score": 50071.453, "text_hl": "RESULTS: Age or physical activity did not correlate with blood @<m>DISEASE_Pressure_Ulcer</m> @DISEASE_MESH:D003668 @@@pressure@@@ response to @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@. ", "citations": {"NLM": "de la Sierra A. [Relationship between sympathetic activity and response to treatment with atenolol in hypertensive patients. Investigation group of the study of efficiency and tolerance of atenolol in hypertensive patients with increase in the sympathetic activity]. Med Clin (Barc). 1999 Jun 19;113(2):41-5. PMID: 10425617", "BibTeX": "@article{10425617, title={[Relationship between sympathetic activity and response to treatment with atenolol in hypertensive patients. Investigation group of the study of efficiency and tolerance of atenolol in hypertensive patients with increase in the sympathetic activity].}, author={de la Sierra A}, journal={Med Clin (Barc)}, volume={113}, number={2}, pages={41-5}}"}}, {"_id": "2892458", "pmid": 2892458, "title": "[Comparative pharmacoclinical study of 2 beta-blockers: atenolol and betaxolol in slight-to-moderate arterial hypertension].", "journal": "Ann Cardiol Angeiol (Paris)", "authors": ["Herpin D", "Boutaud P", "Ciber MA", "Amiel A", "Demange J"], "date": "1987-11-01T00:00:00Z", "meta_date_publication": "1987 Nov", "meta_volume": "36", "meta_issue": "9", "meta_pages": "487-93", "score": 50067.93, "text_hl": "The maximal effect on resting supine blood @<m>DISEASE_Pressure_Ulcer</m> @DISEASE_MESH:D003668 @@@pressure@@@ occurred later with @CHEMICAL_Betaxolol @CHEMICAL_MESH:D015784 @@@betaxolol@@@ (4th day) than with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ (1st day), while the effect on peak exercise-blood @<m>DISEASE_Pressure_Ulcer</m> @DISEASE_MESH:D003668 @@@pressure@@@ and heart rate was rapidly maximal (1st day) for both beta-blockers. ", "citations": {"NLM": "Herpin D, Boutaud P, Ciber MA, Amiel A, Demange J. [Comparative pharmacoclinical study of 2 beta-blockers: atenolol and betaxolol in slight-to-moderate arterial hypertension]. Ann Cardiol Angeiol (Paris). 1987 Nov;36(9):487-93. PMID: 2892458", "BibTeX": "@article{2892458, title={[Comparative pharmacoclinical study of 2 beta-blockers: atenolol and betaxolol in slight-to-moderate arterial hypertension].}, author={Herpin D and Boutaud P and Ciber MA and Amiel A and Demange J}, journal={Ann Cardiol Angeiol (Paris)}, volume={36}, number={9}, pages={487-93}}"}}, {"_id": "17444886", "pmid": 17444886, "title": "Irbesartan reduces common carotid artery intima-media thickness in hypertensive patients when compared with atenolol: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) study.", "journal": "J Intern Med", "authors": ["Mörtsell D", "Malmqvist K", "Held C", "Kahan T"], "date": "2007-05-01T00:00:00Z", "doi": "10.1111/j.1365-2796.2007.01775.x", "meta_date_publication": "2007 May", "meta_volume": "261", "meta_issue": "5", "meta_pages": "472-9", "score": 50067.836, "text_hl": "RESULTS: With similar reductions in blood @<m>DISEASE_Pressure_Ulcer</m> @DISEASE_MESH:D003668 @@@pressure@@@, CCA intima-media thickness (IMT) was reduced by @CHEMICAL_Irbesartan @CHEMICAL_MESH:D000077405 @@@irbesartan@@@ (from 0.92 +/- 0.14 by 0.01 +/- 0.10 mm, NS), whereas it was increased by @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ (from 0.94 +/- 0.21 by 0.03 +/- 0.12 mm, P=0.018; P=0.002 between groups). ", "citations": {"NLM": "Mörtsell D, Malmqvist K, Held C, Kahan T. Irbesartan reduces common carotid artery intima-media thickness in hypertensive patients when compared with atenolol: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) study. J Intern Med. 2007 May;261(5):472-9. PMID: 17444886", "BibTeX": "@article{17444886, title={Irbesartan reduces common carotid artery intima-media thickness in hypertensive patients when compared with atenolol: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) study.}, author={Mörtsell D and Malmqvist K and Held C and Kahan T}, journal={J Intern Med}, volume={261}, number={5}, pages={472-9}}"}}, {"_id": "1974506", "pmid": 1974506, "title": "Efficacy and safety of carvedilol in comparison with atenolol in hypertensive patients pretreated with hydrochlorothiazide.", "journal": "Eur J Clin Pharmacol", "authors": ["van der Does R", "Widmann L", "Uberbacher HJ", "Hörrmann M", "Machwirth M", "Stienen U"], "date": "1990-01-01T00:00:00Z", "doi": "10.1007/BF01409486", "meta_date_publication": "1990", "meta_volume": "38 Suppl 2", "meta_issue": "", "meta_pages": "S147-52", "score": 50067.31, "text_hl": "@CHEMICAL_Carvedilol @CHEMICAL_MESH:D000077261 @@@Carvedilol@@@ [25 mg once daily] (o.d.) was compared to @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ (50 mg o.d.) as an adjunct to pre-existing @CHEMICAL_Hydrochlorothiazide @CHEMICAL_MESH:D006852 @@@hydrochlorothiazide@@@ (@CHEMICAL_Hydrochlorothiazide @CHEMICAL_MESH:D006852 @@@HCTZ@@@) monotherapy in @SPECIES_9606 @@@patients@@@ with mild to moderate @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ [diastolic blood @<m>DISEASE_Pressure_Ulcer</m> @DISEASE_MESH:D003668 @@@pressure@@@ (DBP), 100-115 mm Hg]. ", "citations": {"NLM": "van der Does R, Widmann L, Uberbacher HJ, Hörrmann M, Machwirth M, Stienen U. Efficacy and safety of carvedilol in comparison with atenolol in hypertensive patients pretreated with hydrochlorothiazide. Eur J Clin Pharmacol. 1990;38 Suppl 2():S147-52. PMID: 1974506", "BibTeX": "@article{1974506, title={Efficacy and safety of carvedilol in comparison with atenolol in hypertensive patients pretreated with hydrochlorothiazide.}, author={van der Does R and Widmann L and Uberbacher HJ and Hörrmann M and Machwirth M and Stienen U}, journal={Eur J Clin Pharmacol}, volume={38 Suppl 2}, pages={S147-52}}"}}, {"_id": "2841053", "pmid": 2841053, "title": "Effects of atenolol and enalapril on blood pressure, plasma renin activity and urinary prostanoids.", "journal": "Clin Invest Med", "authors": ["Wilson TW"], "date": "1988-06-01T00:00:00Z", "meta_date_publication": "1988 Jun", "meta_volume": "11", "meta_issue": "3", "meta_pages": "203-8", "score": 50065.3, "text_hl": "Both drugs lowered blood @<m>DISEASE_Pressure_Ulcer</m> @DISEASE_MESH:D003668 @@@pressure@@@: placebo 147/97, @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ 135/87, @CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@enalapril@@@ 132/87 (p less than 0.05, for both). ", "citations": {"NLM": "Wilson TW. Effects of atenolol and enalapril on blood pressure, plasma renin activity and urinary prostanoids. Clin Invest Med. 1988 Jun;11(3):203-8. PMID: 2841053", "BibTeX": "@article{2841053, title={Effects of atenolol and enalapril on blood pressure, plasma renin activity and urinary prostanoids.}, author={Wilson TW}, journal={Clin Invest Med}, volume={11}, number={3}, pages={203-8}}"}}, {"_id": "8973753", "pmid": 8973753, "title": "Effects of bunazosin and atenolol on serum lipids and apolipoproteins in a randomised trial.", "journal": "Blood Press", "authors": ["Schmitz G", "Stumpe KO", "Herrmann W", "Weidinger G"], "date": "1996-11-01T00:00:00Z", "doi": "10.3109/08037059609078074", "meta_date_publication": "1996 Nov", "meta_volume": "5", "meta_issue": "6", "meta_pages": "354-9", "score": 50065.176, "text_hl": "Eighty-seven were treated with the alpha-receptor blocker @CHEMICAL_bunazosin @CHEMICAL_MESH:C018176 @@@bunazosin@@@ and the same number with the beta-blocker @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@. Systolic and diastolic blood @<m>DISEASE_Pressure_Ulcer</m> @DISEASE_MESH:D003668 @@@pressure@@@ decreased significantly in both groups, whereas only @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ decreased pulse rate. ", "citations": {"NLM": "Schmitz G, Stumpe KO, Herrmann W, Weidinger G. Effects of bunazosin and atenolol on serum lipids and apolipoproteins in a randomised trial. Blood Press. 1996 Nov;5(6):354-9. PMID: 8973753", "BibTeX": "@article{8973753, title={Effects of bunazosin and atenolol on serum lipids and apolipoproteins in a randomised trial.}, author={Schmitz G and Stumpe KO and Herrmann W and Weidinger G}, journal={Blood Press}, volume={5}, number={6}, pages={354-9}}"}}, {"_id": "16686086", "pmid": 16686086, "title": "[The most recent study into blood pressure lowering by amlodipine: the beginning of the end for the beta-blockers].", "journal": "Ned Tijdschr Geneeskd", "authors": ["van den Meiracker AH", "van Montfrans GA"], "date": "2006-04-22T00:00:00Z", "meta_date_publication": "2006 Apr 22", "meta_volume": "150", "meta_issue": "16", "meta_pages": "886-8", "score": 50065.016, "text_hl": "Most likely related to a lower systolic blood @<m>DISEASE_Pressure_Ulcer</m> @DISEASE_MESH:D003668 @@@pressure@@@, a better metabolic profile and inferiority of the comparator @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@, the trial showed better outcomes for total and cardiovascular mortality, fatal and nonfatal @DISEASE_Stroke @DISEASE_MESH:D020521 @@@stroke@@@ and cardiovascular events and procedures for the combination of newer agents. ", "citations": {"NLM": "van den Meiracker AH, van Montfrans GA. [The most recent study into blood pressure lowering by amlodipine: the beginning of the end for the beta-blockers]. Ned Tijdschr Geneeskd. 2006 Apr 22;150(16):886-8. PMID: 16686086", "BibTeX": "@article{16686086, title={[The most recent study into blood pressure lowering by amlodipine: the beginning of the end for the beta-blockers].}, author={van den Meiracker AH and van Montfrans GA}, journal={Ned Tijdschr Geneeskd}, volume={150}, number={16}, pages={886-8}}"}}, {"_id": "3709638", "pmid": 3709638, "title": "Cadralazine and chlorthalidone as a second-step drug with atenolol in hypertensive patients: differences in blood pressure control during exercise.", "journal": "Eur J Clin Pharmacol", "authors": ["Costa FV", "Borghi C", "Mussi A", "Ambrosioni E"], "date": "1986-01-01T00:00:00Z", "doi": "10.1007/BF00614292", "meta_date_publication": "1986", "meta_volume": "30", "meta_issue": "2", "meta_pages": "145-50", "score": 50064.273, "text_hl": "At the end of treatment with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ and after 3 and 6 months of combination therapy, blood @<m>DISEASE_Pressure_Ulcer</m> @DISEASE_MESH:D003668 @@@pressure@@@ and heart rate were measured at rest and during bicycle exercise 24 h after the last dose. ", "citations": {"NLM": "Costa FV, Borghi C, Mussi A, Ambrosioni E. Cadralazine and chlorthalidone as a second-step drug with atenolol in hypertensive patients: differences in blood pressure control during exercise. Eur J Clin Pharmacol. 1986;30(2):145-50. PMID: 3709638", "BibTeX": "@article{3709638, title={Cadralazine and chlorthalidone as a second-step drug with atenolol in hypertensive patients: differences in blood pressure control during exercise.}, author={Costa FV and Borghi C and Mussi A and Ambrosioni E}, journal={Eur J Clin Pharmacol}, volume={30}, number={2}, pages={145-50}}"}}]}